<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04952324</url>
  </required_header>
  <id_info>
    <org_study_id>MTHFR mutation and GDM</org_study_id>
    <nct_id>NCT04952324</nct_id>
  </id_info>
  <brief_title>MTHFR Mutation and Concentration of B12,Folic Acid,Homocysteine and HS CRP in the Blood of Pregnant Women With GDM.</brief_title>
  <official_title>MTHFR Gene Mutation C6777T and Concentration of Vitamin B12, Folic Acid, Homocysteine and High Sensitive CRP in the Blood of Pregnant Women With Gestational Diabetes Mellitus.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Mostar</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Mostar</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Research hypothesis:&#xD;
&#xD;
        -  pregnant women with gestational diabetes have elevated serum CRP values and homocysteine&#xD;
           compared to pregnant women with normal glucose metabolism&#xD;
&#xD;
        -  Elevated CRP and homocysteine values are associated with poorer perinatal outcome.&#xD;
&#xD;
        -  reduced concentrations of folic acid and vitamin B 12 are associated with higher&#xD;
           homocitein values&#xD;
&#xD;
        -  Carriers of the MTHFR gene mutation have higher homocysteine concentrations&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Research issues:&#xD;
&#xD;
      The basic pathophysiological mechanism of gestational diabetes is insulin resistance formed&#xD;
      as a result of the production of placental hormones. It turned out as atherosclerosis,&#xD;
      chronic cardiovascular diseases and diabetes share common pathophysiological mechanisms,&#xD;
      which is nonphysiological activation of the endothelium. CRP is an acute phase protein that&#xD;
      is synthesized in the liver to stimulate IL-6. It is a sensitive marker of inflammation and&#xD;
      good predictor of the development of preeclampsia while the research results CRP as a&#xD;
      predictor of gestational diabetes inconsistent. Homocysteine is a marker of endothelial&#xD;
      dysfunction and oxidative stress. Elevated homocysteine levels are a factor risk of&#xD;
      cardiovascular disease, and in pregnancy is associated with preeclampsia, spontaneous&#xD;
      abortions and placental abruption.Proper adjustment of uteroplacental blood vessels is&#xD;
      necessary for the orderly course of pregnancy these deviations from normal endothelial&#xD;
      function will lead to pregnancy disorders.&#xD;
&#xD;
      This study is an extrapolation of recognized markers of cardiovascular risk to gestational&#xD;
      diabetes for the purpose of predicting an adverse perinatal outcome. Examined the association&#xD;
      of the combination of the hs-CRP marker and homocysteine with gestational diabetes and&#xD;
      pregnancy outcome and the correlation of homocysteine and folic acid concentration acid and&#xD;
      vitamin B12.&#xD;
&#xD;
      Research hypothesis:&#xD;
&#xD;
        -  pregnant women with gestational diabetes have elevated serum CRP values and homocysteine&#xD;
           compared to pregnant women with normal glucose metabolism&#xD;
&#xD;
        -  Elevated CRP and homocysteine values are associated with poorer perinatal outcome.&#xD;
&#xD;
        -  reduced concentrations of folic acid and vitamin B 12 are associated with higher&#xD;
           homocitein values&#xD;
&#xD;
        -  Carriers of the MTHFR gene mutation have higher homocysteine concentrations&#xD;
&#xD;
      Research goals:&#xD;
&#xD;
        -  compare serum values of hs-CRP and homocysteine in pregnant women with gestational&#xD;
           diabetes and in the control group of pregnant women with a regular sugar load test&#xD;
&#xD;
        -  determine the existence of an association between the values of hs-CRP and homocysteine&#xD;
           with complications of pregnancy.&#xD;
&#xD;
        -  determine the existence of a correlation between the values of vitamin B12 and folic&#xD;
           acid with serum homocysteine values&#xD;
&#xD;
        -  determine the association of MTHFR gene mutation and homocysteine concentration The&#xD;
           objectives of the research are achievable by the proposed research.&#xD;
&#xD;
      Respondents:&#xD;
&#xD;
        -  Study group: 100 pregnant women hospitalized for sugar profile in the Department&#xD;
           pathology of pregnancy, Clinic for Gynecology and Obstetrics, SKB Mostar, and which was&#xD;
           previously diagnosed with gestational diabetes&#xD;
&#xD;
        -  Control group: 100 pregnant women with a regular glucose load test, and which meet the&#xD;
           inclusion criteria&#xD;
&#xD;
      Criteria for inclusion in the research:&#xD;
&#xD;
        -  Age of respondents from 18 to 35 years&#xD;
&#xD;
        -  Single pregnancies BMI from 18.5 to 29.9 kg / m 2&#xD;
&#xD;
      Exclusion criteria:&#xD;
&#xD;
        -  Diagnosis of acute and chronic inflammatory diseases&#xD;
&#xD;
        -  Pregestational diabetes&#xD;
&#xD;
        -  Chronic hypertension&#xD;
&#xD;
        -  Multiple pregnancies&#xD;
&#xD;
        -  Smoking&#xD;
&#xD;
      This enzyme is important for the metabolism of folate, B12, homocysteine.The diagnosis of&#xD;
      gestational diabetes will be based on the results of the HAPO study, which is also accepted&#xD;
      by the WHO. All respondents will be measured values of hs-CRP, homocysteine, folic acid and&#xD;
      vitamin B12 in serum, at gestational age between 24-28 weeks of gestation and compare between&#xD;
      test and control groups. The correlation of folate acid and vitamin B12 it will be examined&#xD;
      the conection between homocysteine values in serum.&#xD;
&#xD;
      Using patients' medical histories we will monitore examined parameters: birth weight and&#xD;
      length of the newborn, Apgar sum newborns in the 1st and 5th minutes, the development of&#xD;
      hypertensive pregnancy disorders (hypertension, preeclampsia), HbA1c, BMI values and weight&#xD;
      gain in pregnancy, gestational age, frequency of induced labor, cesarean section and&#xD;
      surgically completed vaginal delivery, frequency of shoulder dystocia, presence meconium&#xD;
      fruits, polyhydramnios, oligohydramnios and hypothyroidism. Statistical analysis of the data&#xD;
      will assess the association of pregnancy outcomes with hs-CRP and homocysteine values in both&#xD;
      study groups of pregnant women.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 1, 2020</start_date>
  <completion_date type="Anticipated">December 2021</completion_date>
  <primary_completion_date type="Anticipated">December 2021</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>5 Months</target_duration>
  <primary_outcome>
    <measure>Whether increased hs crp and homocysteine values are associated with poorer perinatal outcome</measure>
    <time_frame>Between 24 and 28 weeks of gestation</time_frame>
    <description>We will meassure hs CRP and homocysteine levels in pregnant women with GDM and compare to hs CRP and homocysteine levels in pregnant women with normal glucose metabolism</description>
  </primary_outcome>
  <primary_outcome>
    <measure>carriers of the MTHFR gene mutation have higher serum homocysteine concentrations in the blood</measure>
    <time_frame>Between 24 and 28 weeks of gestation</time_frame>
    <description>We will compare serum homocysteine levels in pregnant carriers of the MTHFR gene mutation and pregnant women normal MTHFR gene mutation.</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Gestational Diabetes</condition>
  <arm_group>
    <arm_group_label>Pregnant women with GDM</arm_group_label>
    <description>Pregnant women with GDM</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Pregnant women without GDM</arm_group_label>
    <description>Pregnant women without GDM</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Blood sampling and determination of MTHFR mutation,vitamin B12, folic acid, homocystein and HS CRP</intervention_name>
    <description>Periferal Blood sampling and determination of MTHFR mutation,vitamin B12, folic acid, homocystein and high sensitive CRP</description>
    <arm_group_label>Pregnant women with GDM</arm_group_label>
    <arm_group_label>Pregnant women without GDM</arm_group_label>
  </intervention>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Periferal blood.&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Population of women who were hospitalized at the gynecology and obstretics clinic in&#xD;
        Mostar.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  age of respondents from 18 to 35 years&#xD;
&#xD;
          -  Single pregnancies BMI from 18.5 to 29.9 kg / m 2&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Diagnosis of acute and chronic inflammatory diseases&#xD;
&#xD;
          -  Pregestational diabetes&#xD;
&#xD;
          -  Chronic hypertension&#xD;
&#xD;
          -  Multiple pregnancies&#xD;
&#xD;
          -  Smoking&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <gender_description>Pregnant women</gender_description>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>35 Years</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Vajdana Tomic, prof. dr</last_name>
    <role>Study Chair</role>
    <affiliation>Faculty of Health Studies, Mostar</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ana Boskovic, mr.sc</last_name>
    <phone>0038763432754</phone>
    <email>anamarkoti@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Faculty of health studies, Mostar</name>
      <address>
        <city>Mostar</city>
        <zip>88000</zip>
        <country>Bosnia and Herzegovina</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ana Boskovic, mr. sc</last_name>
      <phone>0038763432754</phone>
      <email>anamarkoti@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Vajdana Tomic, prof.dr</last_name>
      <email>tomicvajdana5@gmail.com</email>
    </contact_backup>
    <investigator>
      <last_name>Vedrana Mandrapa, md</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ana Šimić, mr.sc</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Mostar</name>
      <address>
        <city>Mostar</city>
        <zip>88000</zip>
        <country>Bosnia and Herzegovina</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ana Boskovic, mr. sc</last_name>
      <phone>0038763432754</phone>
      <email>anamarkoti@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Vajdana Tomic, prof.sc</last_name>
      <email>tomicvajdana5@gmail.com</email>
    </contact_backup>
    <investigator>
      <last_name>Vedrana Mandrapa, md.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ana Šimić, mr.sc</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Bosnia and Herzegovina</country>
  </location_countries>
  <link>
    <url>https://pubmed.ncbi.nlm.nih.gov/19667406/</url>
    <description>Chemical pathology of homocysteine. IV. Excitotoxicity, oxidative stress, endothelial dysfunction, and inflammation</description>
  </link>
  <link>
    <url>https://pubmed.ncbi.nlm.nih.gov/25531073/</url>
    <description>First-Trimester Screening for Gestational Diabetes Mellitus Based on Maternal Characteristics and History</description>
  </link>
  <link>
    <url>https://pubmed.ncbi.nlm.nih.gov/23994612/</url>
    <description>Endothelial dysfunction - a major mediator of diabetic vascular disease</description>
  </link>
  <link>
    <url>https://pubmed.ncbi.nlm.nih.gov/26110385/</url>
    <description>Inflammatory and Other Biomarkers: Role in Pathophysiology and Prediction of Gestational Diabetes Mellitus</description>
  </link>
  <verification_date>June 2021</verification_date>
  <study_first_submitted>May 31, 2021</study_first_submitted>
  <study_first_submitted_qc>June 26, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">July 7, 2021</study_first_posted>
  <last_update_submitted>June 26, 2021</last_update_submitted>
  <last_update_submitted_qc>June 26, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 7, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Mostar</investigator_affiliation>
    <investigator_full_name>Ana Bošković</investigator_full_name>
    <investigator_title>mr. sc. Ana Boskovic, Ob/Gyn specialist</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes, Gestational</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Folic Acid</mesh_term>
    <mesh_term>Vitamin B 12</mesh_term>
    <mesh_term>Hydroxocobalamin</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>All of the individual participant data collected during the trial, after deidentification.</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Statistical Analysis Plan (SAP)</ipd_info_type>
    <ipd_info_type>Informed Consent Form (ICF)</ipd_info_type>
    <ipd_info_type>Clinical Study Report (CSR)</ipd_info_type>
    <ipd_info_type>Analytic Code</ipd_info_type>
    <ipd_time_frame>Beginnibg 3 months and ending 5 Years folowing article publication.</ipd_time_frame>
    <ipd_access_criteria>Investigators whose proposed use the Data has been approved by an Independent review committee identified for this purpose.</ipd_access_criteria>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

